Financial Data and Key Metrics Changes - Total revenue for Q1 2025 declined 4% year over year to $15.9 million, with online sales accounting for 67% of total revenue at $10.6 million [3][4] - Gross profit decreased by 6%, and gross margin fell from 44% in Q1 2024 to 43.1% in Q1 2025 [4] - Net income for Q1 2025 was $2 million, down from $2.2 million in Q1 2024, with basic earnings per share declining from 23¢ to 22¢ and diluted earnings per share from 21¢ to 20¢ [4][5] - Adjusted EBITDA for Q1 2025 was $3.4 million, a 6% decrease compared to the previous year [5] - The company ended the quarter with $12 million outstanding on term loans and no balance on its revolving line of credit, resulting in net debt of $6 million, approximately 0.4 times the company's adjusted EBITDA for the past twelve months [5][12] Business Line Data and Key Metrics Changes - Legacy FitLife revenue for Q1 2025 was $7.3 million, with wholesale customers contributing 63% and online sales 37%, representing a 5% increase in total revenue [6] - MRC revenue for Q1 2025 was $6.7 million, down 11% year over year, with gross margin declining to 45.4% [7] - Muscle Farm revenue declined 6% in Q1 2025, with wholesale revenue down 41% and online revenue up 33% [9][10] Market Data and Key Metrics Changes - The tariff environment remains uncertain, particularly concerning tariffs on ingredients from China, although a recent 90-day de-escalation was announced [11] - The company has increased inventory levels at pre-tariff prices, resulting in an all-time high inventory balance [11] Company Strategy and Development Direction - The company aims to continue investing in promotional support for Muscle Farm products to drive growth, despite the challenges faced [10][15] - Management believes there is significant opportunity for consolidation in the nutritional supplement space, indicating a focus on M&A activities [69] Management's Comments on Operating Environment and Future Outlook - Management expressed hope for organic revenue growth in 2025, despite not providing formal guidance [19] - April performance showed year-over-year increases in total revenue and adjusted EBITDA, although results may not be indicative of the entire second quarter [15] Other Important Information - The company has approximately 104,000 active subscribers, accounting for about 30% of online revenue [13] - FitLife is expected to be added to the Russell 2000 index, which could serve as a positive catalyst for the stock [14] Q&A Session Summary Question: Changes in revenue and EBITDA expectations - Management reiterated expectations for organic revenue growth in 2025, without providing specific numbers [19] Question: Margins outlook for the year - Margins are expected to fluctuate based on product mix, with Muscle Farm aiming for around 30% gross margin [21][22] Question: Performance of wholesale customers - Some customers are seeing increased end consumer demand, while others are not achieving desired results from promotional support [28][30] Question: Status of major customer GNC - The relationship with GNC is positive, with improved inventory levels compared to late last year [35] Question: New product launches - New products, including bars and ready-to-drink beverages, are performing well, with expectations for increased sales in Q2 [48] Question: Impact of tariffs on products - Some products benefit from tariff exclusions, while others do not, leading to a variable impact on costs [50][52] Question: Long-term prospects for Muscle Farm - Management is focused on rebuilding the Muscle Farm brand and sees potential for growth despite past challenges [62][64] Question: Valuation multiples for acquisitions - Valuation multiples for prospective deals remain consistent, typically around 6-7x for rapidly growing businesses [72]

[Q1 2025 Financial & Operational Highlights](index=1&type=section&id=FitLife%20Brands%20Announces%20First%20Quarter%202025%20Results) The company reported a slight revenue decline in Q1 2025, with stable profitability metrics and a strengthened net debt position Key Financial Metrics | Financial Metric | Q1 2025 | Q1 2024 | Change | | :--- | :--- | :--- | :--- | | Total Revenue | $15.9 million | $16.5 million | -4% | | Online Revenue | $10.6 million | $10.8 million (approx) | -2% | | Wholesale Revenue | $5.3 million | $5.7 million (approx) | -7% | | Gross Margin | 43.1% | 44.0% | -0.9 p.p. | | Net Income | $2.0 million | $2.2 million | -9.1% | | Adjusted EBITDA | $3.4 million | $3.65 million | -6% | | Basic EPS | $0.22 | $0.23 | -4.3% | | Diluted EPS | $0.20 | $0.21 | -4.8% | - Online sales constituted **67%** of total revenue in Q1 2025, an increase from **65%** in Q1 2024[4](index=4&type=chunk) - The company ended the quarter with **$6.0 million in cash** and **$12.0 million in outstanding term loans**, resulting in a **net debt of $6.0 million**. This represents a leverage ratio of approximately **0.4x trailing twelve months adjusted EBITDA**[6](index=6&type=chunk)[8](index=8&type=chunk) - Excluding elevated merger and acquisition-related expenses in Q1 2025, net income and EPS would have been comparable or higher than the prior-year period[7](index=7&type=chunk) [Performance by Brand Segment](index=2&type=section&id=Performance%20of%20Acquired%20Brands) This section details the varied performance of the company's brand segments, including Legacy FitLife, Mimi's Rock, and MusclePharm [Legacy FitLife](index=3&type=section&id=Legacy%20FitLife) Legacy FitLife demonstrated strong performance in Q1 2025, with a 5% increase in total revenue driven by an 11% growth in online sales. Both gross profit and contribution saw an 11% increase, and margins expanded compared to the prior year Legacy FitLife Segment Performance | (in thousands) | Q1 2024 | Q1 2025 | Change | | :--- | :--- | :--- | :--- | | Total revenue | $6,961 | $7,299 | +5% | | Gross profit | $2,928 | $3,254 | +11% | | Gross margin | 42.1% | 44.6% | +2.5 p.p. | | Contribution | $2,848 | $3,169 | +11% | | Contribution as a % of revenue | 40.9% | 43.4% | +2.5 p.p. | - The revenue growth was driven by an **11% increase in online revenue** and a **2% increase in wholesale revenue**[12](index=12&type=chunk) [Mimi's Rock (MRC)](index=3&type=section&id=Mimi's%20Rock%20(MRC)) MRC's performance declined in Q1 2025, with an 11% decrease in revenue and a 14% drop in gross profit year-over-year. The decline was primarily driven by lower sales in its largest brand, Dr. Tobias, and changes in product mix, although contribution margin improved due to optimized advertising spend Mimi's Rock (MRC) Segment Performance | (in thousands) | Q1 2024 | Q1 2025 | Change | | :--- | :--- | :--- | :--- | | Total revenue | $7,493 | $6,674 | -11% | | Gross profit | $3,520 | $3,030 | -14% | | Gross margin | 47.0% | 45.4% | -1.6 p.p. | | Contribution | $2,458 | $2,236 | -9% | | Contribution as % of revenue | 32.8% | 33.5% | +0.7 p.p. | - Revenue for the largest MRC brand, Dr. Tobias, decreased by **11%**. The decline in gross margin was primarily due to a change in product mix within the Dr. Tobias brand[14](index=14&type=chunk)[17](index=17&type=chunk) - The increase in contribution as a percentage of revenue was a result of continued optimization of advertising spend across all MRC brands[17](index=17&type=chunk) [MusclePharm](index=4&type=section&id=MusclePharm) MusclePharm's revenue decreased by 6% in Q1 2025, as a 41% drop in wholesale revenue overshadowed a 33% increase in online sales. The wholesale decline was attributed to a large customer's inventory build-up from a Q4 2024 promotion. The company is making targeted investments and launched a new product line to drive future growth MusclePharm Segment Performance | (in thousands) | Q1 2024 | Q1 2025 | Change | | :--- | :--- | :--- | :--- | | Total revenue | $2,095 | $1,963 | -6% | | Wholesale revenue | $1,117 | $658 | -41% | | Online revenue | $978 | $1,305 | +33% | | Gross margin | 40.0% | 30.1% | -9.9 p.p. | | Contribution as % of revenue | 35.9% | 21.2% | -14.7 p.p. | - The decrease in wholesale revenue was primarily due to one customer overstocking during a Q4 2024 promotion without a corresponding increase in sell-through, affecting Q1 2025 reorders[18](index=18&type=chunk) - In March 2025, the company launched the new MusclePharm Pro Series in a pilot program with Vitamin Shoppe, with plans for a 12-month exclusive rollout if successful[20](index=20&type=chunk) [Consolidated Financial Performance](index=5&type=section&id=FitLife%20Consolidated) The company's consolidated results show a slight decline in revenue, gross profit, and contribution, with margins remaining largely stable year-over-year Consolidated Performance Metrics | (in thousands) | Q1 2024 | Q1 2025 | Change | | :--- | :--- | :--- | :--- | | Total revenue | $16,549 | $15,936 | -4% | | Gross profit | $7,287 | $6,874 | -6% | | Gross margin | 44.0% | 43.1% | -0.9 p.p. | | Contribution | $6,059 | $5,821 | -4% | | Contribution as % of revenue | 36.6% | 36.5% | -0.1 p.p. | - On a consolidated basis, revenue, gross profit, and contribution all decreased by **4-6%** compared to the first quarter of 2024, with gross margin and contribution margin remaining relatively stable[22](index=22&type=chunk) [Management Commentary](index=5&type=section&id=Management%20Commentary) Management discusses brand performance, strategic initiatives, and financial flexibility for future growth and M&A opportunities - The CEO noted that the strong performance of the Legacy FitLife business helped offset challenges faced by the MRC and MusclePharm brands, demonstrating the benefit of a diversified brand portfolio[23](index=23&type=chunk)[26](index=26&type=chunk) - The decline in MusclePharm's wholesale revenue was attributed to a large customer's reduced orders after a Q4 promotional buy-in; however, orders from this customer in **Q2 2025** have already surpassed the entire **Q1** volume[24](index=24&type=chunk) - MRC's online revenue faced challenging year-over-year comparisons, with the Dr. Tobias brand seeing a **16% decline in February** and a **12% decline in March**[25](index=25&type=chunk) - The company is encouraged by strong cash flow generation, which has reduced net debt leverage to approximately **0.4x adjusted EBITDA**. This provides financial flexibility to pursue sizable M&A opportunities in a market with elevated deal flow[27](index=27&type=chunk) [Financial Statements](index=8&type=section&id=Financial%20Statements) This section presents the company's condensed consolidated balance sheets, statements of income, and statements of cash flows [Condensed Consolidated Balance Sheets](index=8&type=section&id=FITLIFE%20BRANDS%2C%20INC.%20CONDENSED%20CONSOLIDATED%20BALANCE%20SHEETS) As of March 31, 2025, the company's balance sheet shows an increase in total assets to $62.2 million, driven by higher cash and inventories. Total liabilities rose slightly to $23.3 million, while stockholders' equity increased to $38.9 million from $36.1 million at year-end 2024 Condensed Consolidated Balance Sheets (in thousands) | (In thousands) | March 31, 2025 (Unaudited) | December 31, 2024 | | :--- | :--- | :--- | | **ASSETS** | | | | Cash and cash equivalents | $5,941 | $4,468 | | Total current assets | $21,759 | $18,143 | | **TOTAL ASSETS** | **$62,193** | **$58,531** | | **LIABILITIES & EQUITY** | | | | Total current liabilities | $13,296 | $11,311 | | Term loan, net | $7,436 | $8,550 | | **TOTAL LIABILITIES** | **$23,275** | **$22,405** | | **TOTAL STOCKHOLDERS' EQUITY** | **$38,918** | **$36,126** | | **TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY** | **$62,193** | **$58,531** | [Condensed Consolidated Statements of Income](index=9&type=section&id=FITLIFE%20BRANDS%2C%20INC.%20CONDENSED%20CONSOLIDATED%20STATEMENTS%20OF%20INCOME) For the first quarter of 2025, the company reported revenue of $15.9 million, a 4% decrease from the prior year. Operating income was $3.0 million, and net income was $2.0 million, resulting in diluted earnings per share of $0.20, compared to $0.21 in Q1 2024 Condensed Consolidated Statements of Income (in thousands) | (In thousands, except per share data) | Three months ended March 31, 2025 | Three months ended March 31, 2024 | | :--- | :--- | :--- | | Revenue | $15,936 | $16,549 | | Gross profit | $6,874 | $7,287 | | Operating income | $2,958 | $3,381 | | Net income | $2,018 | $2,160 | | Basic EPS | $0.22 | $0.23 | | Diluted EPS | $0.20 | $0.21 | - Merger and acquisition related expenses increased to **$332 thousand** from **$134 thousand** in the prior-year quarter, impacting operating income[36](index=36&type=chunk) [Condensed Consolidated Statements of Cash Flows](index=10&type=section&id=FITLIFE%20BRANDS%2C%20INC.%20CONDENSED%20CONSOLIDATED%20STATEMENTS%20OF%20CASH%20FLOWS) The company generated $2.3 million in cash from operating activities in Q1 2025, a decrease from $5.0 million in Q1 2024, mainly due to changes in working capital. Cash was primarily used for $1.1 million in term loan repayments. The company ended the quarter with a net cash increase of $1.5 million Condensed Consolidated Statements of Cash Flows (in thousands) | (In thousands) | Three months ended March 31, 2025 | Three months ended March 31, 2024 | | :--- | :--- | :--- | | Net cash provided by operating activities | $2,328 | $5,036 | | Net cash used in investing activities | ($24) | ($10) | | Net cash used in financing activities | ($866) | ($3,625) | | **Change in cash and restricted cash** | **$1,474** | **$1,392** | | **Cash and restricted cash, end of period** | **$5,994** | **$3,290** | [Non-GAAP Measures Reconciliation](index=11&type=section&id=Non-GAAP%20Measures) This section provides a reconciliation of non-GAAP financial measures, including EBITDA and Adjusted EBITDA, to their most directly comparable GAAP measures - The company uses non-GAAP measures like **EBITDA** and **Adjusted EBITDA** to exclude items not indicative of core operating results, such as interest, taxes, depreciation, amortization, stock-based compensation, and M&A expenses[39](index=39&type=chunk)[40](index=40&type=chunk) Reconciliation of Non-GAAP Measures (in thousands) | (In thousands) | Three months ended March 31, 2025 | Three months ended March 31, 2024 | | :--- | :--- | :--- | | Net income | $2,018 | $2,160 | | Interest expense/income, net | $218 | $409 | | Foreign exchange loss | $21 | $5 | | Provision for income taxes | $701 | $807 | | Depreciation and amortization | $19 | $36 | | **EBITDA** | **$2,977** | **$3,417** | | Stock compensation expense | $107 | $102 | | Merger and acquisition related expense | $332 | $134 | | **Adjusted EBITDA** | **$3,416** | **$3,653** |

Financial Performance - Total revenue for Q1 2025 was $15,936, a decrease of 3.7% from $16,549 in Q1 2024[14] - Gross profit for Q1 2025 was $6,874, down 5.7% from $7,287 in Q1 2024[14] - Operating income decreased to $2,958 in Q1 2025, compared to $3,381 in Q1 2024, reflecting a decline of 12.5%[14] - Net income for Q1 2025 was $2,018, a decrease of 6.6% from $2,160 in Q1 2024[14] - Revenue for the three months ended March 31, 2025 decreased 4% to $15,936 compared to $16,549 for the same period in 2024[94] - Gross profit for the three months ended March 31, 2025 decreased 6% to $6,874 compared to $7,287 for the same period in 2024[99] - Net income for the three months ended March 31, 2025 was $2,018, a decrease of 7% from $2,160 in the same period in 2024[103] - Total operating expenses for the three months ended March 31, 2025 were $3,916, slightly up from $3,906 in the same period in 2024[94] Cash Flow and Assets - Cash and cash equivalents increased to $5,941 as of March 31, 2025, up from $4,468 at the end of 2024[13] - Total assets rose to $62,193 as of March 31, 2025, compared to $58,531 at the end of 2024, marking an increase of 6.3%[13] - Total stockholders' equity increased to $38,918 as of March 31, 2025, up from $36,126 at the end of 2024, reflecting a growth of 7.7%[13] - Net cash provided by operating activities for Q1 2025 was $2,328, down from $5,036 in Q1 2024[19] - Cash provided by operating activities decreased to $2,328 for the three months ended March 31, 2025, down from $5,036 for the same period in 2024, primarily due to increases in working capital[134] - Cash used in financing activities decreased to $866 for the three months ended March 31, 2025, compared to $3,625 for the same period in 2024, mainly due to voluntary debt repayment[135] Inventory and Debt - As of March 31, 2025, the total inventory amounted to $12,131 million, an increase from $11,074 million as of December 31, 2024, with finished goods at $10,881 million and components at $1,326 million[63] - The total allowance for obsolescence for inventory items decreased to $76 million as of March 31, 2025, from $100 million as of December 31, 2024[63] - The Company’s total debt obligations decreased to $11,936 million as of March 31, 2025, down from $13,050 million as of December 31, 2024[65] - The outstanding balance on Term Loans was $12,000 million as of March 31, 2025, down from $13,125 million as of December 31, 2024[72] - The borrowings outstanding on the Term Loans as of March 31, 2025, were $12,000 million, with no outstanding balance on the Line of Credit[131] Revenue Sources and Trends - Online revenue accounted for approximately 67% of net revenue for the quarter ended March 31, 2025, compared to 65% in the same period of the prior year, indicating a growth in online sales[33] - Sales to customers in the U.S. remained stable at approximately 96% for both the three months ended March 31, 2025, and 2024[34] - Total net sales to GNC represented 16% of total revenue for the three months ended March 31, 2025, down from 25% in the same period of 2024[38] - MusclePharm revenue decreased 6% to $1,963 for the three months ended March 31, 2025, compared to $2,095 for the same period in 2024[97] - MRC revenue decreased 11% to $6,674 for the three months ended March 31, 2025, compared to $7,493 for the same period in 2024[96] - Legacy FitLife revenue increased 5% to $7,299 for the three months ended March 31, 2025, driven by an 11% increase in online revenue and a 2% increase in wholesale revenue[96] Marketing and Product Development - The Company continues to focus on expanding its product offerings and distribution channels, including e-commerce platforms[20] - The Company launched the new MusclePharm Pro Series in March 2025, targeting high-volume Vitamin Shoppe stores[116] - The Company is investing $1 million in research and development for new health and wellness products[170] - The company plans to implement a new marketing strategy focusing on digital channels, expecting a 30% increase in online engagement[170] - FitLife Brands, Inc. has introduced a new line of protein supplements, projected to contribute $500,000 in revenue within the first six months[170] Compliance and Governance - The Company operates as a single reportable segment, with financial performance evaluated on a consolidated basis[56] - The Company is in compliance with all covenants as of March 31, 2025, including maintaining a Fixed Charge Coverage Ratio of not less than 1.25 to 1.00[71] - Management believes that cash flow from operations and available borrowings under the Line of Credit will provide sufficient capital necessary to operate the business over the next twelve months[133] - Management concluded that no triggering event for impairment occurred during the three months ended March 31, 2025[142] - The Company evaluates its estimates and assumptions regularly, with actual results potentially differing from these estimates[140] Sustainability and Future Outlook - The management emphasized a commitment to sustainability, aiming for a 25% reduction in packaging waste by 2026[170] - FitLife Brands, Inc. anticipates a revenue growth forecast of 12% for the upcoming quarter, driven by new product launches[170] - The company is exploring potential acquisition opportunities to enhance its product portfolio[170] - User data showed a growth in active subscribers by 10,000, reaching a total of 150,000 subscribers[170]

Core Insights - FitLife Brands, Inc. reported a total revenue of $15.9 million for Q1 2025, a decrease of 4% compared to $16.5 million in Q1 2024 [3][9] - Online revenue accounted for 67% of total revenue, amounting to $10.6 million, which is a 2% decline from the previous year [3][9] - The company's gross margin for the quarter was 43.1%, down from 44.0% in the same period last year [4][9] - Net income for Q1 2025 was $2.0 million, compared to $2.2 million in Q1 2024, with basic and diluted earnings per share at $0.22 and $0.20, respectively [5][9] - Adjusted EBITDA for the quarter was $3.4 million, a 6% decrease from the previous year, bringing the trailing twelve months adjusted EBITDA to $13.9 million [6][9] Revenue Breakdown - Total revenue for the first quarter was $15.9 million, a 4% decrease year-over-year [3][9] - Online sales were $10.6 million, representing 67% of total revenue, down 2% from the previous year [3][9] - Wholesale revenue was $5.3 million, a 7% decrease compared to the same period last year [3][9] Profitability Metrics - Gross margin for Q1 2025 was 43.1%, compared to 44.0% in Q1 2024 [4][9] - Net income decreased to $2.0 million from $2.2 million year-over-year [5][9] - Adjusted EBITDA was $3.4 million, a 6% decrease from the same period in 2024 [6][9] Brand Performance - Legacy FitLife revenue increased by 5% year-over-year, driven by an 11% increase in online revenue and a 2% increase in wholesale revenue [10][11] - MRC revenue decreased by 11% year-over-year, with the largest brand, Dr. Tobias, also seeing an 11% decline [12][13] - MusclePharm revenue decreased by 6%, with wholesale revenue down 41% but online revenue up 33% [15][16] Management Commentary - The CEO noted that the first quarter was strong for Legacy FitLife but challenging for MRC and MusclePharm [20] - The decline in MusclePharm's wholesale revenue was attributed to reduced purchases from a large customer [21] - The company is optimistic about cash flow generation and has a net debt of approximately 0.4x adjusted EBITDA, indicating financial flexibility for potential acquisitions [24]

Core Points - FitLife Brands, Inc. plans to report its financial performance for Q1 of fiscal 2025 on May 15, 2025 [1] - An investor conference call will be held on the same day at 4:30 pm ET, with specific dialing instructions provided for U.S. and international participants [2] - FitLife Brands develops and markets over 250 nutritional supplements and wellness products, primarily targeting health-conscious consumers [3]

Core Insights - True value in investments is derived from growth rather than short-term gains, emphasizing a long-term perspective on evaluation [1] - Great businesses provide significant societal value and exhibit durability, deserving growth proportional to their superiority [1] - Key characteristics sought in businesses include selection, convenience, value, and durability, with a preference for non-cyclical operations [1] Business Characteristics - Businesses that consistently outperform competitors through superior products and services are favored [1] - The ability to create multiple revenue streams and maintain anti-fragile structures is essential for long-term success [1] - Uniqueness is identified as the primary driver of value, with low maintenance costs allowing for high reinvestment potential [1] Management and Strategy - Trust and network effects are critical indicators of a business's durability [1] - Management quality is paramount, with a preference for executives who have aligned interests and a strong focus on the business [1] - Successful companies, like Amazon, demonstrate that a customer-centric approach can yield extraordinary returns [1] Investment Timing and Strategy - The optimal time for investment is when negative news is fully priced in, revealing true value [1] - Companies that can withstand adversity and show resilience are more attractive for investment [1] - A strategy of buying back shares is recommended for businesses with durable models, particularly during downturns [1]

Core Insights - FitLife Brands, Inc. announced the resignation of Todd Ordal from its Board of Directors, effective April 25, 2025, as part of its commitment to refresh board composition in line with good corporate governance practices [1][4] - Shannon Pappas has been appointed as an independent director to fill the vacancy left by Mr. Ordal and will serve on the Audit, Compensation, and Nominating/Corporate Governance Committees [2] - Ms. Pappas brings over 25 years of experience in beauty, skincare, health, fitness, and consumer goods, with expertise in strategic growth, digital commerce, financial management, and market expansion [3] Company Developments - The Board of Directors expressed gratitude for Todd Ordal's contributions over his ten years of service, highlighting his role in strategy, marketing, and organizational effectiveness [4] - The company anticipates further changes to the Board composition in the coming years as part of its governance practices [5] - FitLife Brands is a developer and marketer of nutritional supplements and wellness products, offering over 250 products primarily online and through various retail locations [6]

Company Overview - FitLife Brands, Inc. is a developer and marketer of innovative and proprietary nutritional supplements and wellness products aimed at health-conscious consumers [2] - The company offers over 250 different products, primarily marketed online, as well as through domestic and international GNC® franchise locations and various retail outlets [2] - FitLife is headquartered in Omaha, Nebraska [2] Upcoming Presentation - FitLife Brands will present at the Planet MicroCap Showcase: VEGAS 2025 on April 23, 2025, at 9:30 AM PST [1] - The presentation will be hosted by Dayton Judd, the Company's Chairman & CEO, and Ryan Hansen, the Executive Vice President, who will also answer questions afterward [1] Event Information - Investors can access the live presentation and a recording will be available afterward [2][4] - The event is organized in partnership with MicroCapClub, targeting the MicroCap investing community [3]

Company Overview - FitLife Brands Inc. (FTLF) shares increased by 13.1% to close at $13.34, following a period of 12.7% loss over the past four weeks, indicating a significant rebound in investor sentiment [1] - The stock's price surge was supported by high trading volume, with more shares exchanged than usual [1] Insider Activity - Investor optimism was bolstered by director Todd Ordal purchasing 300 shares at $12.07 per share on April 15, and another director, Matthew Lingenbrink, acquiring 3,000 shares for approximately $36,510 [2] Earnings Expectations - FitLife Brands is projected to report quarterly earnings of $0.24 per share, reflecting a year-over-year increase of 9.1%, while revenues are expected to be $15.84 million, a decrease of 4.3% from the previous year [3] - The consensus EPS estimate has been revised 100% lower over the last 30 days, which typically does not correlate with price appreciation [4] Industry Context - FitLife Brands operates within the Zacks Medical - Products industry, where another company, LeMaitre Vascular (LMAT), reported a 1.9% increase in stock price, closing at $86.28, with a slight decline of 0.2% over the past month [4] - LeMaitre's consensus EPS estimate remains unchanged at $0.50, representing a year-over-year increase of 13.6%, and it holds a Zacks Rank of 2 (Buy) [5]

FitLife Brands, Inc. (NASDAQ:FTLF) Q4 2024 Results Conference Call March 27, 2025 4:30 PM ET Company Participants Dayton Judd - Chief Executive Officer Jakob York - Chief Financial Officer Conference Call Participants Ryan Meyers - Lake Street Capital Markets Samir Patel - Askeladden Capital James Bogan - Legend Capital Igor Novgorodtsev - Lares Capital Sean McGowan - ROTH Capital Partners Operator Good day, and welcome to the FitLife Brands' Fourth Quarter 2024 Financial Results. At this time, all particip ...